Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Screening for colorectal neoplasms].

A Shani1, P Rozen, A Fink

  • 1Oncology Unit, Kaplan Hospital, Rehovot.

Harefuah
|January 15, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of a tibial osseointegrated prosthesis as a limb salvage method in two dogs.

Australian veterinary journal·2025
Same author

Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay.

ESMO open·2025
Same author

Advances in aquatic animal health within the framework of the World Organisation for Animal Health.

Revue scientifique et technique (International Office of Epizootics)·2024
Same author

The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis.

ESMO open·2024
Same author

Sustainable aquaculture through the One Health lens.

Nature food·2023
Same author

A seafood risk tool for assessing and mitigating chemical and pathogen hazards in the aquaculture supply chain.

Nature food·2023
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

The leukocyte adherence inhibition (LAI) test showed limited efficacy for early colorectal neoplasm detection compared to the Hemoccult test. While positive in high-risk individuals, LAI had a lower predictive value for neoplasms.

Area of Science:

  • Oncology
  • Gastroenterology
  • Immunology

Background:

  • Colorectal neoplasms pose a significant health burden.
  • Early detection is crucial for improving patient outcomes.
  • Identifying effective screening methods for high-risk groups is essential.

Purpose of the Study:

  • To evaluate the efficacy of the leukocyte adherence inhibition (LAI) test for early detection of colorectal neoplasms.
  • To compare the LAI test's performance against the fecal occult blood (Hemoccult) test and endoscopic procedures.
  • To assess the LAI test's utility as a risk marker in individuals at high risk for colorectal cancer.

Main Methods:

  • Screening of high-risk individuals including first-degree relatives of cancer patients, patients with a history of colorectal adenoma/carcinoma, and those with a history of breast/gynecological cancer or inflammatory bowel disease.

Related Experiment Videos

  • Comparison of LAI test results with Hemoccult test results and findings from sigmoidoscopy or colonoscopy.
  • Inclusion of a control group of normal volunteers for comparative analysis.
  • Main Results:

    • Out of 782 fully screened individuals, 121 (15.5%) had adenomas and 5 (0.6%) had invasive cancer.
    • The LAI test was positive in 21% of high-risk individuals and 7.5% of controls.
    • The Hemoccult test was positive in 4.8% of individuals, with neoplasms found in one-third of those positive, yielding a 33% predictive value compared to 16% for the LAI test.

    Conclusions:

    • The studied groups represented individuals genuinely at high risk for colorectal neoplasms.
    • The LAI test demonstrated insufficient sensitivity for detecting benign adenomas but may serve as an additional risk marker.
    • Further long-term follow-up of high-risk individuals with positive LAI tests is warranted to identify a truly high-risk subgroup.